BXPHF (Botanix Pharmaceuticals) Accounts Payable: $9.48 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Botanix Pharmaceuticals Accounts Payable?

Botanix Pharmaceuticals BXPHF +14.04% Accounts Payable is $9.48 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Botanix Pharmaceuticals's Accounts Payable for the quarter that ended in Dec. 2025 was $9.48 Mil.

Botanix Pharmaceuticals's quarterly Accounts Payable increased from Dec. 2024 ($3.69 Mil) to Jun. 2025 ($5.77 Mil) and increased from Jun. 2025 ($5.77 Mil) to Dec. 2025 ($9.48 Mil).

Botanix Pharmaceuticals's annual Accounts Payable increased from Jun. 2023 ($0.93 Mil) to Jun. 2024 ($1.81 Mil) and increased from Jun. 2024 ($1.81 Mil) to Jun. 2025 ($5.77 Mil).

Botanix Pharmaceuticals Accounts Payable Related Terms

Botanix Pharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Botanix Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Botanix Pharmaceuticals Accounts Payable Chart

Botanix Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 3.98 0.93 1.81 5.77

Botanix Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.47 1.81 3.69 5.77 9.48

Botanix Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $9.48 Mil mean?
Botanix Pharmaceuticals (BXPHF) has a Accounts Payable of $9.48 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Botanix Pharmaceuticals and its competitors.
Is Botanix Pharmaceuticals' Accounts Payable too high?
Botanix Pharmaceuticals' current Accounts Payable is $9.48 Mil.
How does Botanix Pharmaceuticals' Accounts Payable compare to VRTX and REGN?
Botanix Pharmaceuticals' Accounts Payable of $9.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Botanix Pharmaceuticals and its competitors. Botanix Pharmaceuticals's current Accounts Payable is $9.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Botanix Pharmaceuticals stock overvalued right now?
Botanix Pharmaceuticals (BXPHF) has a current Accounts Payable of $9.48 Mil. The current Accounts Payable is $9.48 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Botanix Pharmaceuticals (BXPHF), the current Accounts Payable is $9.48 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Botanix Pharmaceuticals Business Description

Other Exchanges BOT:Australia
Address 41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system for all skin diseases. The company's product pipeline includes BTX 1503 - Moderate to Severe Acne, BTX 1204 - Atopic Dermatitis, BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is derived from Australia.